Senores Pharmaceuticals is a globally oriented, research-centric pharmaceutical organization dedicated to the development and production of a wide array of pharmaceutical products. With a solid foothold in both regulated and emerging markets, the company operates in diverse therapeutic areas and offers various dosage forms. Its expertise lies in identifying, formulating, and manufacturing specialty, niche, and complex pharmaceutical products, making it a trusted partner for select clients.

The company has built strategic collaborations in regulated markets with prominent international and Indian pharmaceutical firms, including Prasco LLC, Lannett Company Inc., Jubilant Cadista Pharmaceuticals Inc., Alkem Laboratories, Sun Pharmaceuticals, Dr. Reddy’s Laboratories Inc., and Cipla USA Inc. Senores Pharmaceuticals emphasizes serving the regulated markets of the US and Canada while extending its footprint to emerging markets in 43 countries. It has successfully secured registrations for 205 products and has filed applications for an additional 406 products.

In addition to its focus on pharmaceuticals, the company is engaged in the manufacturing of critical care injectables and active pharmaceutical ingredients (APIs). As of September 30, 2024, the organization employed 145 individuals on its payroll.